Wolverine Venture Fund Invests In NeuMoDx Molecular
NN ARBOR - The Wolverine Venture Fund, managed by students at The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, announced it has invested in NeuMoDx Molecular Inc., a privately held diagnostics company developing a new platform for high throughput, low cost molecular testing.